CYP1A1 gene and GSTM1 gene polymorphism and the combined effects and risk of lung cancer: A meta-analysis

Chinese Journal of Lung Cancer

Volumn 14, Issue 8, 2011, Pages 660-668

  Li, Cheng ^a   Yin, Zhihua ^a   Zhou, Baosen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cytochrome P450A1 (CYP1A1); Genetic polymorphism; Glutathione S transferase M1 (GSTM1); Lung neoplasms; Meta analysis

Indexed keywords

CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1; ISOLEUCINE; VALINE;

ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CYP1A1 GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GSTM1 GENE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LUNG CANCER; RISK ASSESSMENT; SYSTEMATIC REVIEW;

CHINA; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 80051724646     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.08.05     Document Type: Article

References (32)

1. Lu ZY, Zhong NS ed. Internal Medicine. 7th ed. Beijing: People Medical Publishing House, 2009. 123-134.
2. Frova C. Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng, 2006, 23(4): 149-169.
3. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 1995, 30(6): 445-600.
4. Houlston RS. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 1999, 8(8): 675-682.
5. McWilliams JE, Sanderson BJ, Harris EL, et al. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 1995, 4(6): 589-594.
6. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 2002, 23(8): 1343-1350.
7. Omiecinski CJ, Redlich CA, Costa P. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res, 1990, 50(14): 4315-4321.
8. Landi MT, Bertazzi PA, Shields PG, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 1994, 4(5): 242-246.
9. Drakoulis N, Cascorbi I, Brockmoller J, et al. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region. Clin Investig, 1994, 72(3): 240-248.
10. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: URL:http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm [cited 2009 Oct 19].
11. Qu YH, Shi YB, Zhong LJ, et al. The genotypes of cytochrome P4501A1 and GSTM1 in Non-smoking Female Lung Cancer. Tumor, 1998, 18(2): 80-82.
12. Nakachi K, Imai K, Hayashi S, et al. Polymorphisms of CYP1A1 and glutathione S-T ransfease genes associated with susceptibility to lung cancer in elation to cigarette dose in a Japanese population. Cancer Res, 1993, 53(13): 2994-2999.
13. Persson I, Johansson I, Lou YC, et al. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer, 1999, 81(3): 325-329.
14. Xue KX, Xu L, Chen SQ, et al. Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population. Chin J Med Genet, 2001, 18(2): 125-127.
15. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res, 1992, 83(8): 866-870.
16. Quinones L, Lucas D, Godoy J, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett, 2001, 174(1): 35-44.
17. Zhang LZ, Wang X, Hao XZ, et al. Relationship between susceptibility to lung cancer and genetic polymorphism in P4501A1, GSTM1. Chin J Clin Oncol, 2002, 29(8): 536-540.
18. Nimura Y, Yokoyama S, Fujimori M, et al. Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer, 1997, 80(5): 852-857.
19. Cote ML, Yoo W, Wenzlaff AS, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 2009, 30(4): 626-635.
20. Chang FH, Hu TM, Wang G, et al. Relationship between CYP1A1 and GSTM1 genetic polymorphisms and lung cancer susceptibility in population of Inner Mongolia. Chin J Lung Cancer, 2006, 9(5): 413-417.
21. Gu YF, Zhang SC, Lai BT. Relationship between genetic polymorphism of metabolizing enzymes and lung cancer susceptibility. Chin J Lung Cancer, 2004, 7(2): 112-117.
22. Li Y. Cytochrome P450 1A1 and Glutathione S-transferase M1 polymorphisms and susceptibility to lung cancer. Zhengzhou University, 2004.
23. Li Y, Chen J, He X, et al. CYP1A1 and GSTM1 polymorphisms and susceptibility to lung cancer. J Zhengzhou University (Medical Science), 2006, 41(6): 1061-1064.
24. Hong YS, Chang JH, Kwon OJ, et al. Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med, 1998, 30(4): 192-198.
25. Jin Y, Xu H, Zhang C, et al. Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. BMC Cancer, 2010, 10: 422.
26. Wang DQ, Chen SD, Wang BG, et al. A case control study on relationship between lung cancer and genetic polymorphism of CYP1A1, CYP2E1 and GSTM1 in Han Nationality in Guangzhou area. Bulletin of Chinese Cancer, 2006, 15(9): 579-582.
27. Zhu XX, Hu CP, Gu QH. CYP1 A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in nonsmoking women. Chin J Tuberc Respir Dis, 2010, 33(11): 817-822.
28. Xia Y, Sun QF, Shang B, et al. Polymorphisms of the cytochrome P450 and glutathion s-transferase genes associated with lung cancer susceptibility for the residents in high radon-exposed area. Chin J Radiol Med Prot, 2006, 28(4): 327-332.
29. Song N, Tan W, Xing D, et al. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 2001, 22(1): 11-16.
30. Wang BG, Zhou WP, Li ZB, et al. A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer. Chin J Oncol, 2004, 26(2): 93-97.
31. Alexandrie AK, Nyberg F, Warholm M, et al. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev, 2004, 13(6): 908-914.
32. Hung RJ, Boffetta P, Brockmoller J, et al. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis, 2003, 24(5): 875-882.